Vaccine Composition Formulated with a Novel <i>Lactobacillus</i>-Derived Exopolysaccharides Adjuvant Provided High Protection against <i>Staphylococcus aureus</i>

Vaccine Composition Formulated with a Novel <i>Lactobacillus</i>-Derived Exopolysaccharides Adjuvant Provided High Protection against <i>Staphylococcus aureus</i>

A vaccine that effectively targets methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) is urgently needed, and has been the focus of studies by numerous research groups, but with limited success to date. Recently, our team found that exopolysaccharides derived from probiotic <i&...

Full description

Bibliographic Details
Main Authors: Haochi Zhang, Na Pan, Cheng Ma, Bohui Liu, Lei Xiu, He Tong, Shouxin Sheng, Yanchen Liang, Haotian Li, Fangfei Ma, Xuemei Bao, Wei Hu, Xiao Wang
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Vaccines
Subjects:
exopolysaccharides
vaccine
<i>S. aureus</i>
γδ T cells
IL-17A
Online Access:https://www.mdpi.com/2076-393X/9/7/775

Internet

https://www.mdpi.com/2076-393X/9/7/775

Similar Items